<DOC>
	<DOCNO>NCT00339079</DOCNO>
	<brief_summary>This study compare effectiveness cognitive behavioral therapy , antidepressant medication , combination two treat hypochondriasis .</brief_summary>
	<brief_title>Treatment Hypochondriasis With CBT and/or SSRI</brief_title>
	<detailed_description>Hypochondriasis one difficult psychiatric disorder treat . People hypochondriasis believe real imagined physical symptom sign serious illness , despite medical reassurance evidence contrary . Symptoms disorder include preoccupation fear illness ; persistent fear serious illness , despite medical reassurance ; misinterpretation symptom . Some individual hypochondriasis recognize fear serious illness may excessive , unreasonable , unfounded . Episodes hypochondriasis usually last month year , equally long period remission . Cognitive behavioral therapy ( CBT ) antidepressant drug fluoxetine ( FLX ) show effective treatment hypochondriasis . However , relative efficacy combine approach yet determine . This study compare effectiveness cognitive behavioral therapy , antidepressant medication , combination two treat hypochondriasis . Participants double-blind study first report study site two session determine eligibility participation . Eligible individual randomly assign receive one follow four treatment 12 week : CBT ; FLX ; CBT plus FLX ; placebo pill . All participant receive medication also receive supportive therapy . Treatment response assess Week 12 , participant show improvement continue study additional 12 week . Participants respond treatment remove study receive open treatment . Participants assign receive medication placebo take medication daily full 24 week . Participants assign CBT CBT plus FLX receive CBT weekly first 8 week , biweekly Week 12 , monthly week 24 . Outcomes assess study visit Weeks 6 , 12 , 24 , 48 , phone Week 36 .</detailed_description>
	<mesh_term>Hypochondriasis</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Inclusion Criteria Meets DSMIV criterion hypochondriasis ; ascertain Structured Diagnosis Hypochondriasis module SCIDI , meet hypochondriasis severity rating least `` moderate '' . Drug free 6 week psychoactive investigational medication ( seven week fluoxetine ) . Approval treat physician concomitant psychoactive medication need withdraw prior study participation . English fluency literacy . Exclusion Criteria Pregnant nursing mother woman childbearing potential take adequate birth control precaution . Any following Axis I mental disorder : chronic pain syndrome , schizophrenia , schizoaffective disorder , delusional disorder , bipolar disorder , alcohol abuse dependence disorder ( current within last six month ) , substance abuse dependence disorder ( current within last twelve month ) . Patients comorbid psychiatric disorder eligible base follow three criterion : hypochondriasis must predominant present disorder ; patient major comorbid psychiatric disorder rat `` severe '' Clinical Global Impressions Scale ( CGI Scale ) ; patient comorbid psychiatric disorder cause significant functional impairment ( significant functional impairment define impairment interferes mark way expect role functioning , vocational and/or interpersonal ) . Suicidality within last 6 month establish score 9 suicidality module MINI Plus . Symptomcontingent pending litigation , disability compensation , worker ' compensation proceeding Major medical illness expect worsen significantly , lead hospitalization , likely prove fatal next six month , establish Cumulative Illness Rating Scale ( CIRS ) ; Stable , chronic medical illness exclusion criterion Not able withdraw concomitant psychoactive medication currently take necessary medication might interact adversely fluoxetine : Clinically important abnormality ECG , laboratory test ( include thyroid function ) physical examination . `` Clinically important '' abnormality signify treatment intervention need medical abnormality sufficiently address . Patients medical problem stable chronic eligible , patient medical problem unstable , acute , inadequately evaluate exclude . A current electrocardiogram require patient symptom suggestive cardiac disease , include chest pain , dyspnea , palpitation , lightheadedness ; current electrocardiogram exists , study obtain one . History severe side effect associate fluoxetine noncompliance prior CBT hypochondriasis Previous adequate trial either fluoxetine ( eight week two week minimum dose 60 mg/day ) CBT hypochondriasis ( least four session specifically target hypochondriacal symptom ) exclude , regardless prior response . Inability ambulate mobility restriction prohibit frequent travel hospital treatment evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>